
zzso zzso zzso leads to multiple sclerosis zzso objective of this study is to compare disease activity in zzso patients who continued on zzso treatment to those who were switched to subcutaneous zzso zzso zzso zzso 

zzso randomized, zzso zzso pilot study zzso zzso zzso zzso zzso zzso patients on zzso for zzso months who had been free of disease activity on this therapy (no relapses and disability progression for zzso months, no zzso zzso on baseline zzso were zzso to zzso or zzso zzso zzso was time to first zzso zzso Additional clinical, zzso and safety parameters were zzso Analysis was based on intention to zzso 

19 patients zzso zzso zzso zzso with similar baseline characteristics were zzso zzso of zzso treated patients remained zzso free zzso group: zzso and zzso remained free of new zzso zzso zzso group: zzso While time to first zzso zzso was not significantly different between groups zzso many secondary clinical and zzso zzso zzso of zzso proportion of zzso free patients, number of new zzso zzso showed a trend, or were significant (new zzso zzso at month 6) in favoring zzso 

zzso therapy from zzso to zzso over 1 year was associated with some clinical and zzso disease zzso zzso no major safety concerns were zzso 

